We are live on
!
Find out more
CEI
Clark Estates Inc Portfolio holdings
AUM
$434M
1-Year Est. Return
15%
This Fund
S&P 500
1 Year Est. Return
+15%
AUM
$434M
AUM Growth
+$17.5M
(+4.2%)
Holding
108
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 | +$25.8M | |
| 2 | +$9.71M | |
| 3 | +$3.76M | |
| 4 |
Best Buy
BBY
|
+$2.9M |
| 5 |
Sony
SONY
|
+$2.81M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 | +$15M | |
| 2 | +$11.8M | |
| 3 | +$7.5M | |
| 4 |
Solventum
SOLV
|
+$6.56M |
| 5 |
Medtronic
MDT
|
+$5.24M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 29.82% |
| 2 | Technology | 13.51% |
| 3 | Communication Services | 11.78% |
| 4 | Consumer Staples | 7.78% |
| 5 | Consumer Discretionary | 5.68% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1
Euclidean Fundamental Value ETF
ECML
$131M
| $66.7M | 15.37% |
1,722,782
-396,700
|
|
||
2
Vanguard FTSE Developed Markets ETF
VEA
$239B
| $26.4M | 6.1% |
+371,060
|
|
||
3
Unilever
UL
$134B
| $22.2M | 5.13% |
370,000
+65,000
|
|
||
4
Walt Disney
DIS
$184B
| $19.3M | 4.44% |
200,000
|
|
||
|
AMRZ
5
Amrize Ltd
AMRZ
$25.5B
| $17.3M | 3.99% |
325,000
+40,000
|
|
||
|
6
Sony
SONY
$142B
| $16.5M | 3.82% |
825,000
+133,400
|
|
||
7
Haleon
HLN
$42.8B
| $15.9M | 3.66% |
1,700,000
+300,000
|
|
||
|
8
Solventum
SOLV
$15.2B
| $15.4M | 3.56% |
200,000
-90,000
|
|
||
9
Bausch + Lomb
BLCO
$6.05B
| $14.6M | 3.36% |
881,000
+56,000
|
|
||
10
Warner Music
WMG
$13.4B
| $14.5M | 3.34% |
535,000
-115,000
|
|
||
11
Henry Schein
HSIC
$10B
| $11.3M | 2.6% |
135,000
+127,000
|
|
||
12
IQVIA
IQV
$39.1B
| $10.1M | 2.32% |
52,185
-43,015
|
|
||
13
Shattuck Labs
STTK
$748M
| $9.93M | 2.29% |
1,430,167
-45,481
|
|
||
|
14
Medtronic
MDT
$117B
| $7.04M | 1.62% |
90,000
-65,000
|
|
||
15
John Wiley & Sons Class A
WLY
$2.61B
| $4.58M | 1.06% |
94,400
+27,400
|
|
||
16
3D Systems Corp
DDD
$613M
| $4.28M | 0.99% |
1,418,614
|
|
||
17
Smith & Nephew
SNN
$12.5B
| $4.13M | 0.95% |
143,500
-76,500
|
|
||
18
Pediatrix Medical
MD
$2.16B
| $3.88M | 0.89% |
153,000
+24,000
|
|
||
19
Indivior Pharmaceuticals
INDV
$4.59B
| $3.79M | 0.87% |
92,300
|
|
||
|
CPRX
20
DELISTED
Catalyst Pharmaceutical
CPRX
| $3.58M | 0.83% |
113,918
|
|
||
21
Halozyme
HALO
$11.2B
| $3.51M | 0.81% |
44,868
|
|
||
22
Altria Group
MO
$110B
| $3.5M | 0.81% |
48,613
|
|
||
23
Crocs
CROX
$6.3B
| $3.49M | 0.8% |
28,900
|
|
||
|
24
Best Buy
BBY
$18.2B
| $3.32M | 0.76% |
+43,700
|
|
||
25
Biogen
BIIB
$31.1B
| $3.31M | 0.76% |
15,300
|
|
Similar funds
GDS
GPP
ACG
TECP
HCM
DCM
WPW
BMC
Clark Estates Inc's Q2 2026 Portfolio in Review
As of Q2 2026, Clark Estates Inc held 108 positions worth $434M, up 4.2% from $416M the previous quarter. Its ten largest holdings account for 53% of the portfolio.
Clark Estates Inc's Q2 2026 filing shows 11 new, 17 increased, 16 reduced and 18 closed positions. Its largest new stake was Vanguard FTSE Developed Markets ETF: 371,060 shares worth $26.4M. The largest sale was Euclidean Fundamental Value ETF, an estimated $15M.
By sector, the portfolio is most concentrated in Healthcare at 30% of assets, down from 34% a quarter earlier, followed by Technology and Communication Services.
- Clark Estates Inc's largest Q2 2026 buy was Vanguard FTSE Developed Markets ETF: 371,060 shares worth $26.4M.
- Clark Estates Inc added most to Henry Schein in Q2 2026, an estimated $9.71M increase.
- Clark Estates Inc's biggest Q2 2026 reduction was Euclidean Fundamental Value ETF, cutting an estimated $15M.
- Clark Estates Inc fully exited Avanos Medical in Q2 2026, selling an estimated $11.8M.
- Clark Estates Inc's ten largest holdings make up 53% of its $434M portfolio in Q2 2026.
- Clark Estates Inc opened 11 new positions and closed 18 in Q2 2026.
- Clark Estates Inc's portfolio value rose 4.2% quarter-over-quarter to $434M.
Based on Clark Estates Inc's 13F filing for Q2 2026, filed 5 Aug 2026.